Biotech Spotlight: Aurina Pharmaceuticals Inc, SCYNEXIS Inc, and The Medicines Company

Among the drugmakers in focus are Aurina Pharmaceuticals Inc (NASDAQ:AUPH), SCYNEXIS INc (NASDAQ:SCYX), and The Medicines Company (NASDAQ:MDCO)

Oct 6, 2016 at 11:12 AM
facebook twitter linkedin


A handful of biotech stocks are making big moves today. Among the drugmakers in focus are Aurina Pharmaceuticals Inc (NASDAQ:AUPH), SCYNEXIS Inc (NASDAQ:SCYX), and The Medicines Company (NASDAQ:MDCO).

  • AUPH is the best-performing Nasdaq stock thus far, up 31.6% at $5.33, after the company reported encouraging data for Voclosporin, its lead treatment for lupus nephritis. The shares of AUPH have officially closed their August bear gap -- triggered by concerns of patient deaths related to the aforementioned drug -- to touch a fresh multi-year high of $5.69 earlier. A few recent short sellers could be kicking rocks, as short interest on Aurina Pharmaceuticals Inc skyrocketed more than 300% during the past two reporting periods.

  • SCYX is 4.8% higher at $5.03, after the firm unveiled the results of two Phase 2 studies and said it closed a $15 million term loan with Solar Capital Ltd. (NASDAQ:SLRC). The stock has rocketed 189% since touching a record low of $1.74 in mid-July, and is on pace to topple its 50-week moving average for the first time in more than a year. Analysts are already in SCYNEXIS Inc's corner, though, with all four covering brokerage firms doling out "buy" or better endorsements.
  • MDCO is down 13.8% at $33.18, as Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) -- with which it's developing a cholesterol-lowering drug -- gets destroyed. The Medicines Company shares are now south of their 80-day moving average for the first time since late July, landing on the short-sale restricted list. Still, there are likely quite a few shorts cheering today, as more than 19% of MDCO's float is dedicated to short interest. At the stock's average pace of trading, it would take more than three weeks to buy back these bearish bets.

Sign up now for Schaeffer's Market Recap to get all the day's big stock movers, must-know technical levels, and top economic stories straight to your inbox.
 

Minimize Risk While Maximizing Profits

There is no options strategy like this one, which consistently minimizes risk while maintaining maximum profits. Perfect for traders looking for ways to control risk, reduce losses, and increase the likelihood of success when trading calls and puts. The Schaeffer’s team has over 41 years of options trading success targeting +100% gains on every trade. Rest assured your losses are effectively limited to your initial cost at the time of making your move! Don't waste another second... join us right now before the next trade is released! 

 


 


 
Special Offers from Schaeffer's Trading Partners